Jeffrey N Higaki

Title: The Innovations of Jeffrey N. Higaki

Introduction

Jeffrey N. Higaki is a notable inventor based in Mountain View, CA. He has made significant contributions to the field of biotechnology, particularly in the modulation of gamma-secretase activity. With a total of 3 patents, his work has implications for understanding and potentially treating conditions related to beta-amyloid peptide production.

Latest Patents

One of his latest patents focuses on the modulation of gamma-secretase activity. This invention provides a cell-free gamma-secretase activity assay that utilizes a membrane source of APP/gamma-secretase mixture. The method aims to determine factors that may enhance or decrease enzymatic activity affecting beta-amyloid peptide production. The cell membranes used in the assay can be derived from cells expressing an endogenous APP or, preferably, from cells expressing a recombinant APP. The APP may be full-length or a fragment capable of being proteolytically cleaved by gamma-secretase. Additionally, the APP expressed in the cells may have one or more mutations, such as a point mutation or small deletion.

Career Highlights

Throughout his career, Jeffrey has worked with several prominent companies, including Scios Inc. and Merrell Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Jeffrey has collaborated with notable individuals in his field, including Barbara Cordell and Daniel G. Schirlin. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Jeffrey N. Higaki's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the understanding of gamma-secretase activity and its implications for health.